<DOC>
	<DOC>NCT02250469</DOC>
	<brief_summary>12-SMI-2014 is a post-market, randomised, pilot study to identify and rate differences in patient experiences with two different types of Spinal Cord Stimulator devices which are routinely used to treat chronic pain.</brief_summary>
	<brief_title>A Randomised Pilot Study to Assess Differences in Stimulation Induced Paresthesia Between 2 Spinal Cord Stimulation Systems</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Paresthesia</mesh_term>
	<criteria>1. Subject is appropriate for SCS implantation according to standard criteria 2. Subject is &gt;18 to &lt;75 years old 3. Subject is able and willing to comply with the followup schedule and protocol 4. Subject has chronic (&gt; 6 months) uni/bilateral neuropathic pain in the lower limb(s) (below the knee) with predominant foot pain 5. Minimum baseline pain rating of 50 mm on the VAS in the primary region of pain 6. Subject is able to provide written informed consent 1. Subject has no other exclusion criteria for SCS implantation according to standard criteria 2. Subject has had corticosteroid therapy at an intended site of stimulation within the past 30 days 3. Subject has had radiofrequency treatment of an intended target DRG within the past 3 months 4. Subject has participated in another clinical study within 30 days 5. Subject has been previously treated with and failed to respond to an implantable neuromodulation therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>